Image

CBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB

CBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB

Non Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this case series is to explore whether a talking therapy, specifically Cognitive Behavioural Therapy (CBT) is acceptable and feasible in the management of mood-driven impulsive behaviours in people with bipolar disorder (BD).

The main questions it aims to answer are:

  • Whether CBT Is a feasible intervention for participants with BD who report mood-driven, problematic impulsive behaviours.
  • Whether CBT for mood-driven, problematic impulsive behaviours (CBT-PIB) is acceptable to service users with BD and therapists.
  • Whether clinical outcomes are consistent with the potential for this novel intervention to offer clinical benefit to participants with BD.

The study also hopes to:

  • conduct a preliminary examination of the safety of CBT-PIB and the research procedures.
  • gather information on the potential mechanisms of action of CBT-PIB and,
  • gather information on the types of mood-driven impulsive behaviours individuals with BD may seek support for.

Participants will:

  • be offered up to 12 individual sessions of CBT focusing on mood-driven impulsive behaviours.
  • be asked to complete a battery of self-report measures (5) when they enter the study and at the start and end of treatment.
  • be asked to track mood and impulsive behaviours by completing a brief set of measures (3) weekly during the two-week baseline phase, the intervention phase and the 2-week post-intervention phase.
  • be asked to complete a survey on the acceptability of the intervention and
  • be invited to an optional semi-structured interview on their research experience.

Eligibility

Inclusion Criteria:

  • meeting diagnostic criteria for Bipolar I or II Disorder (SCID-5- Structured clinical interview for depression )
  • able to identify at least one impulsive, problematic behaviour to target during the intervention;
  • participants will require working knowledge of written and spoken English, sufficient to be able to make use of therapy and to be able complete research assessments without the need of a translator.

Exclusion Criteria:

  • major depressive episode (identified through SCID-DSM-5);
  • current experience of mania;
  • current/past learning disability (IQ of less than 70 with impairment of social and adaptive functioning)
  • organic brain change or substance dependence (drugs and alcohol) that would compromise ability to use therapy;
  • current marked risk to self (i.e. self-harm or suicide) that we deem could not be appropriately managed in by the therapy site;
  • currently lacking capacity to give informed consent;
  • currently receiving other psychosocial therapy for impulsivity or bipolar disorder;
  • current engagement in another psychological intervention addressing bipolar disorder or impulsivity;
  • presence of another area of difficulty that the therapist and client believe should be the primary focus of intervention (for example, Post-Traumatic Stress Disorder, psychosis).

Study details
    Impulsivity
    Bipolar Disorder
    Hypomania
    Bipolar I Disorder
    Bipolar II Disorder
    Bipolar Affective Disorder
    Impulsive Behavior

NCT06129500

University of Exeter

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.